Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. Dr. Thomas Lienert, Berlin, Germany – FDA Inspections
Company
•Germany

Dr. Thomas Lienert, Berlin, Germany – FDA Inspections

Inspection records and compliance data for Dr. Thomas Lienert in Berlin. 1 FDA inspection on record, last inspected November 03, 2023.

Sign in to open in Dashboard
Company Profile

This profile covers Dr. Thomas Lienert based in Berlin, Germany.

FDA Inspection History

FDA inspections
1
OAI
0
VAI
0
NAI
1
Form 483s
0
Warning letters
0

Inspected November 3, 2023.

FDA inspections (1)

DateResultFDA center(s)Insp. #
November 3, 2023NAIHuman Drugs · Bioresearch Monitoring1223656
FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Premium Cosmetics Gmbh
Syntrion Gmbh
Gehrlicher Pharmazeutische Extrakte GmbH
Leona Plum-Moerschel, MD
Linde Eckstein Gmbh + Co KG
Christian Keicher, M.D.
Karl Baum, M.d.
Ever Pharma Jena GmbH
Synlab Clinical Trial GmbH Berlin
GP Grenzach Produktions GmbH
Company Information

Name

Dr. Thomas Lienert

FEI Number

3027771580

Address

Praxis An Der Oper, Bismarckstr. 30, Berlin, Germany

Country

Germany

ID: 1c34c3b9-3e9d-4a39-b7a5-495b9a0462a1

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.